What Is Atypical Depression? Understanding Symptoms, Causes, and Treatment

Atypical depression is a form of major depressive disorder (MDD) or persistent depressive disorder (dysthymia) characterized by mood reactivity and specific physical and emotional symptoms. People with atypical depression often experience temporary mood improvement in response to positive events but still struggle with persistent low mood or fatigue overall. The term “atypical” can be misleading. This form of depression is common and well-recognized by mental health professionals. Despite its name, atypical depression is not rare, with estimates suggesting it affects 15% to 43% of patients with a depressive disorder. It describes a specific pattern of depressive symptoms that differ from what most people imagine when they think of depression. What makes it “atypical” is that it presents differently than classic depression.

While symptoms vary from person to person, the most common signs of atypical depression include:

• Mood reactivity: Feeling temporarily better when something positive happens

• Increased appetite or weight gain

• Excessive sleepiness or sleeping longer than usual

• Heavy or “leaden” feelings in the arms or legs (a symptom called leaden paralysis)

• Extreme fatigue or anergia (lack of energy or motivation)

• Heightened sensitivity to rejection or criticism

Many people with atypical depression describe feeling emotionally and physically heavy, with a sense that even small tasks require enormous effort. Others report feeling easily hurt or rejected in relationships, which can make social situations stressful or isolating.

The term anergia refers to a state of reduced physical or mental energy. It is common in many depressive disorders but is especially prominent in atypical depression. Anergia can make it difficult to get out of bed, focus on daily responsibilities, or sustain motivation at work or school. People experiencing anergia often describe feeling drained, sluggish, or “stuck in molasses,” even when they have slept well.

Unlike typical major depression, which is often marked by early-morning awakening, loss of appetite, and persistent sadness regardless of external events, atypical depression presents with opposite patterns. Recognizing these distinctions is essential for getting the right diagnosis and treatment plan.

Diagnosing atypical depression involves a physical exam and lab tests to rule out other conditions like chronic fatigue syndrome (CFS), followed by a psychiatric evaluation to compare symptoms against the official diagnostic criteria. Key steps include a physical check-up, possible bloodwork, a detailed interview about symptoms and history. Diagnosis is based on the DSM-IV criteria for depression with atypical features , which specifically requires mood reactivity plus at least two of the following: increased sleep, increased appetite or weight gain, heavy feeling in limbs, and a long-standing pattern of interpersonal rejection sensitivity.

Atypical depression can arise from a combination of biological, psychological, and environmental factors. Research suggests that differences in brain chemistry-especially involving serotonin, dopamine, and norepinephrine-may play a role. Other risk factors include:

• A family history of depression or bipolar disorder
• Hormonal changes, such as during pregnancy or thyroid disorders (including Hashimoto’s disease)
• Chronic stress or trauma
• Certain personality traits, such as heightened sensitivity or perfectionism

Treatment for atypical depression typically involves a combination of psychotherapy and prescribed medication. Therapy: Cognitive Behavioral Therapy (CBT) , interpersonal therapy, and mindfulness-based approaches are often effective for helping individuals identify and reframe negative thinking patterns, manage sensitivity to rejection, and build coping skills. Medication: Medications sometimes used for atypical depression include atypical antidepressants, which should only be taken as prescribed by a qualified clinician. Prescribed antidepressants , especially those that affect dopamine and norepinephrine (such as bupropion ), may be particularly helpful for addressing symptoms like anergia and low motivation. Selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs) are also used, depending on the individual’s needs and medical history. Lifestyle Support: Adequate sleep, physical activity, sunlight exposure, and social connection can all support recovery. For some individuals, addressing co-occurring conditions such as thyroid dysfunction or seasonal affective disorder (SAD) can significantly improve symptoms. In recent years, there have also been several new emerging treatments for depression, including innovative medications, technology-enabled therapies, and at-home wearable devices that support individualized care. These advances are broadening the ways depression, including atypical depression, can be managed and treated in 2026 and beyond.

If you suspect you may be living with atypical depression, reaching out to a psychiatrist is a first step. Depression, in any form, can often be managed with appropriate care and support. The right combination of therapy, medication, and lifestyle changes may help restore energy, motivation, and a sense of emotional balance. According to recent LifeStance data , 73% of patients* experienced improvement in symptoms of depression with treatment. If you or someone you love is struggling with symptoms of depression, contact a LifeStance therapist or psychiatrist today to explore treatment options and work towards feeling better.

• Atypical depression is a recognized subtype of major depressive disorder with specific features like mood reactivity, increased sleep, and heightened sensitivity to rejection.
• Anergia, or extreme fatigue and lack of motivation, is a hallmark symptom.
• Treatment may include a combination of therapy and, when appropriate, prescribed medication.
• With proper diagnosis and care, people with atypical depression may experience meaningful recovery and improved quality of life.

*amongst 150,000 LifeStance patients with at least moderate depression